161 results
Page 4 of 9
8-K
EX-99.1
glcpl8e brg
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
424B5
5vz2vd9b
19 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
0ia42
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
xc53ksm85pxxwc 0xi57
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
q3llna8lumg4i
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
9eqdmhsg5iloeyrz
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
qw0e15ls7st es4
1 Jun 11
Other Events
12:00am
8-K
EX-99.1
frov7vtacp8x1x4s 6o
11 May 11
Results of Operations and Financial Condition
12:00am
424B5
0y0psdrgbx
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
x1wvx
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
as8jmts9y
9 Feb 11
Other Events
12:00am